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Genome maintenance mechanisms actively suppress genetic instability associated with
cancer and aging. Some viruses provoke genetic instability by subverting the host’s control
of genome maintenance. Viruses have their own specialized strategies for genome main-
tenance, which can mimic and modify host cell processes. Here, we review some of the
common features of genome maintenance utilized by viruses and host chromosomes,
with a particular focus on terminal repeat (TR) elements. The TRs of cellular chromo-
somes, better known as telomeres, have well-established roles in cellular chromosome
stability. Cellular telomeres are themselves maintained by viral-like mechanisms, including
self-propagation by reverse transcription, recombination, and retrotransposition. Viral TR
elements, like cellular telomeres, are essential for viral genome stability and propagation.
We review the structure and function of viral repeat elements and discuss how they may
share telomere-like structures and genome protection functions. We consider how viral
infections modulate telomere regulatory factors for viral repurposing and can alter normal
host telomere structure and chromosome stability. Understanding the common strate-
gies of viral and cellular genome maintenance may provide new insights into viral–host
interactions and the mechanisms driving genetic instability in cancer.
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INTRODUCTION
Repetitive DNA elements provide essential functions in genome
maintenance. The repetitive DNA elements at the ends of linear
genomes have been recognized for their special role in prevent-
ing DNA loss due to the “end-replication problem” (Watson,
1972; Olovnikov, 1973). In most eukaryotes, the DNA repeats
at the ends of linear chromosomes are referred to as telomeres
and have essential functions in chromosome end-protection and
genome stability (reviewed in Cech, 2004; Blackburn et al., 2006).
Similar to cellular genomes, many DNA viruses have terminal
repeats (TRs) that are essential for viral genome stability. Indeed,
viral-like elements have been proposed to be the evolutionary
source of cellular telomeres and telomerase (Nosek et al., 2006).
For both viruses and cellular genomes, the function and regu-
lation of these repetitive elements play a critical role in genome
maintenance.
Abbreviations: AAV, adeno-associated virus; ATRX, alpha thalassemia/mental
retardation syndrome X-linked; BNRF1, EBV major tegument protein; CTCF,
CCCTC-binding factor; Daxx, death-domain associated protein; EBER, EBV-
encoded RNA; EBNA1, EBV nuclear antigen 1; EBV, Epstein–Barr virus; ExoI,
exonuclease I; HBV,hepatitis B virus; hCMV,human cytomegalovirus; HCV,hepati-
tis C virus; HHV6, human Herpesvirus 6; HPV, human papillomavirus; HSV, herpes
simplex virus; hTERT, human telomerase reverse transcriptase; ICP0, infected cell
polypeptide 0; IR, intergenic repeats; KSHV, Kaposi’s sarcoma-associated Her-
pesvirus; LANA, latency-associated nuclear antigen; LAT, HSV latency-associated
transcript; LMP1 and 2, EBV latent membrane protein 1 and 2; MDV, Marek’s
disease virus; ORC, origin recognition complex; Ori, viral replication origin;
PML, promyelocytic leukemia; RCC1, regulator of chromosome condensation 1;
TERRA, telomere repeats-containing RNA; TP, terminal-binding protein; TR, ter-
minal repeats; TRF1 and 2, telomere repeat factor 1 and 2; XRCC4, X-ray repair
cross-complementing protein 4.
Most eukaryotic chromosomes have short (5–10 nucleotide)
GC-rich telomere repeat elements that are essential for main-
taining the linear structure of the chromosome. Telomere repeats
can form structured DNA, like G-quadruplexes, that may provide
structural stability to prevent nucleolytic degradation (Huppert,
2008; Qin and Hurley, 2008). Telomere repeats can also serve
as binding sites for proteins that physically cap the ends of lin-
ear chromosomes and facilitate end-replication (de Lange, 2005a;
Palm and de Lange, 2008). A minimal number of telomere
repeats is required for end-protection, and repeat copy num-
ber can be ampliﬁed by specialized mechanisms that include
telomerase-dependent reverse transcription (Cech, 2004; Chan
and Blackburn, 2004), homologous recombination (McEachern
and Haber, 2006; Cesare and Reddel, 2008), and in some organ-
isms, telomere-speciﬁc retrotransposition (Silva-Sousa et al., 2012;
Zhang and Rong, 2012). Telomere repeats can also function in
transcription regulation (Arnoult et al., 2012), chromatin pack-
aging (Schoeftner and Blasco, 2009; Ye et al., 2010b), subcellular
localization (Mai and Garini, 2006), and chromosome segregation
(Houghtaling et al., 2011).
Repetitive DNA elements play a signiﬁcant role in viral genome
biology and maintenance. For linear DNA viruses, TRs are
required for viral genome stability. Functions of viral TRs include
replication initiation, transcription regulation, integration, trans-
position, segregation, and virion packaging. Like telomeres, viral
TRs can vary in size, composition, and copy number. Viral TRs
bind to host and viral proteins, and these protein–DNA interac-
tions are important for viral replication and genome maintenance.
Themechanisms that regulate viral TRhomeostasismay be similar
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to that of cellular telomere repeat copy number maintenance, but
viral-speciﬁc nuances and limited experimental data may limit the
extent of the comparison with cellular processes.
Viral infection can have profound effects on host cell pro-
cesses, including those relevant to telomere biology and genome
maintenance. Viruses that induce host cell proliferation and
immortalization typically induce telomerase and prevent telomere
shortening to escape senescence (Bellon and Nicot, 2008). Linear
DNA viruses encode factors that alter DNA damage recognition
and end-repair that can alter host telomere maintenance. Even cir-
cular viruses can utilize telomere repeat factors for viral genome
maintenance, and indirectly modulate host telomere functions.
Here we review some of the common features of viral and cellular
genome maintenance elements, and how virus infections can alter
host cell telomere maintenance.
TERMINAL STRUCTURE OF VIRAL GENOMES
All linear DNA viruses have specialized mechanisms for genome
end-protection (Figure 1). Pox viruses are large (∼250 kb)
double-stranded DNA molecules with TRs that are covalently
closed hairpins (Traktman and Boyle, 2004). Some prokaryotic
pathogens, including the spirochete Borrelia that causes Lyme
disease, have a similar terminal hairpin structure (Chaconas
and Kobryn, 2010). Both genomes encode a topoisomerase-like
resolvase (A22 for vaccinia and Res T for Borrelia) that cleaves
the terminal hairpin during DNA replication. Pox viruses are
also unusual in that they replicate their DNA genomes in the
host cytoplasm. The cytoplasmic viral genomes may gain addi-
tional protectionby forming specialized replication compartments
consisting of viral-encoded proteins (Novoa et al., 2005). Similar
protective replication compartments are observed in the nucleus
for some viral genomes (e.g., herpesviruses) and may also occur
at cellular sites of replication and repair.
Adenoviruses enter the nucleus as linear genomes with inverted
TRs of ∼100 bp that covalently bind to the viral terminal-
binding protein (TP) during viral replication (de Jong et al., 2003).
Adenovirus TP forms a covalent tyrosine hydroxyl linkage to
DNA, mechanistically related to the action of topoisomerases
and tyrosine recombinases (Yang, 2010). Covalently bound TPs
have been described in prokaryotic linear genomes of strepto-
myces and prophage N15 (Huang et al., 2007). Terminal-binding
proteins provide torsional strain and membrane anchoring in
some organisms (Tsai et al., 2010). Topoisomerases, which mod-
ulate torsional strain, have specialized functions in host cell
telomere DNA replication and DNA end-protection (Temime-
Smaali et al., 2008; Germe et al., 2009; Ye et al., 2010a). Whether
cellular topoisomerases function as end-binding proteins at cel-
lular telomeres during DNA replication remains an intriguing
possibility.
Herpesviruses enter cells as linear genomeswithGC-richTRs of
variable length. Herpesvirus TRs are essential for multiple aspects
of the viral life cycle, including gene expression, DNA replication,
and recombination. The TRs of all herpesvirus genomes contain
recognition sites for terminase, a viral-encoded endonuclease that
generates a unit length linear form of the genome prior to pack-
aging in the viral capsid (Zimmermann and Hammerschmidt,
1995; Bogner, 2002; Nadal et al., 2010). Interestingly, herpesvirus
terminases have RNaseH/integrase-like folds and can be inhibited
by anti-HIV drugs that target integrase (Nadal et al., 2010). The
TRs can expand or contract upon lytic replication, and the copy
number variation can be used as a measure of replication and
clonality (Raab-Traub and Flynn, 1986). The mechanism regulat-
ing TR expansion, copy number control, and fusion are not fully
understood.
Some herpesvirus members [e.g., Epstein–Barr virus (EBV)
and Kaposi’s sarcoma-associated Herpesvirus (KSHV)] circular-
ize upon entry in the nucleus, and form stable minichromosomes
capable of long-term maintenance (Figure 1). The circular
genomes fuse at the TRs and the circular genomes retain variable
numbers of these repeats. Genome circularization is one mecha-
nism through which linear chromosomes can protect their ends
from exonucleolytic attack. In yeast, telomere repeat loss is res-
cued by chromosome circularization (Natarajan and McEachern,
2002; Tomaska et al., 2004). Stable circular human chromo-
somes can also be observed in rare ring-syndromes, but the
genetic basis for this remains unknown (Le Caignec et al., 2004).
In mammalian cells, chromosomes with critically few telom-
ere repeats form inter-telomere fusions (de Lange, 2002; De
Lange, 2005b; Bailey and Murnane, 2006; Bhattacharyya and
Lustig, 2006). Telomere fusions in mammalian cells can occur
through RAD52-dependent homologous recombination, or more
commonly, through Ku-dependent non-homologous end-joining
(Murnane, 2011). The mechanism of herpesvirus circularization
depends on non-homologous end-joining enzymes DNA Ligase
IV and XRCC4 (Muylaert and Elias, 2007), as well as chromosome
condensation protein regulator of chromosome condensation 1
(RCC1; Strang and Stow, 2007), but the molecular details of viral
circularization remains to be determined.
Selective integration into host telomeric DNA appears to be a
common target site for some herpesvirus familymembers. Human
Herpesvirus 6 (HHV6) and Marek’s disease virus (MDV) have
TTAGGG repeats identical to host cell telomere repeats at the
ends of their linear genomes (Arbuckle and Medveczky, 2011).
These telomere repeats facilitate integration and mobility into
host cellular telomeres during viral latency (Arbuckle et al., 2010;
Kaufer et al., 2011b). In addition, MDV encodes a telomerase-
like RNA that can interact with host cell telomerase, but it is not
clear how this modulates telomerase activity, or whether it pro-
motes viral integration at telomeres (Kaufer et al., 2010, 2011a).
HHV6 may encode a replicase similar to adeno-associated virus
(AAV), a parvovirus that integrates into a speciﬁc sequence in
chromosome 19. Targeted integration into the telomere repeats
appears to be mediated by homologous recombination with
genome ends, but telomere targeting may be mediated by other
mechanisms, like those that direct transposition in Drosophila
telomeres.
TELOMERIC FACTORS THAT RECOGNIZE AND REGULATE
VIRAL GENOME MAINTENANCE
Telomere repeat-binding factors (TRFs), including all components
of Shelterin, play a critical role in coordinating telomere repeat
numberwith telomere end-protection,DNAreplication, andDNA
damage response (de Lange, 2005a; Palm and de Lange, 2008).
Telomere repeat factors interact with numerous components of
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FIGURE 1 | Schematic ofViral GenomeTerminal Repeat Structure in
Linear and Circular Conformations. Viral terminal repeats (TR) and
intergenic repeats (IR) are shown as various colored box, indicating different
repetitive sequences. Adenovirus TP and LANA bind to TR of adenovirus and
KSHV, respectively. EBNA1 binds to both FR and DS region of EBV OriP. TRFs
bind to DS region of EBV OriP and MDV OriS, andTRFs-binding sites are
indicated for TR of MDV and HHV6. The terminal hairpin structure for Pox virus
is indicated in pink.
the DNA damage signaling pathways, as well as with compo-
nents of DNA replication and chromatin assembly. As mentioned
above, several viral genomes contain telomere repeat sites, most
notably HHV6 and MDV, which contain TTAGGG-TRs. The TRs
of these viral genomes do not appear to provide episomal stabil-
ity (Bulboaca et al., 1998), but can direct viral genomes toward
host telomere integration during latency (Arbuckle and Med-
veczky, 2011; Arbuckle et al., 2010; Kaufer et al., 2011b). TRF1 and
TRF2 have been suggested to play a role in the integration process
through binding to the TRs. While TRF2 prevents cellular telom-
ere end-to-end fusions (Denchi and de Lange, 2007), it is possible
that viral infection alters TRF function to promote viral inte-
gration by homologous recombination. Other viruses, like EBV,
have functional monomeric TRF-binding sites within the episome
maintenance element, OriP (Deng et al., 2002, 2003). OriP is
an internal repeat element that consists of a family of repeats
(FRs) and a dyad symmetry (DS) element, both of which bind
to the viral-encoded episome maintenance protein EBV nuclear
antigen 1 (EBNA1). The DS element is remarkable for its capac-
ity to initiate bidirectional DNA replication in an EBNA1- and
origin recognition complex (ORC)-dependent manner. The DS
recruits ORC, and TRF2 facilitates and enhances this recruitment
(Deng et al., 2002, 2003; Atanasiu et al., 2006). Disruption of TRF-
binding in DS compromises ORC recruitment, DNA replication,
and episome maintenance of OriP.
Studies from our lab indicated that TRF2 amino terminal basic
domain contributes to ORC recruitment at EBV OriP (Deng et al.,
2002, 2003). TRF2 was also found to recruit ORC to a subset
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of cellular telomeres. The TRF2 basic domain was found to be
similar to the EBNA1 linking region, which contain RGG-like
motifs that have been implicated in both metaphase chromo-
some attachment (Nayyar et al., 2009; Sears et al., 2003, 2004) and
RNA-binding (Snudden et al., 1994). Investigation of the RNA-
binding activity revealed selective interaction with single-stranded
RNA oligonucleotides capable of forming G-quadruplex struc-
tures (Bifﬁ et al., 2012; Norseen et al., 2009). Neither the EBNA1
nor TRF2 RGG-motifs bound single-stranded DNA oligonu-
cleotides with G-quadruplex forming capacity. RNA-binding was
also shown to facilitate interaction with ORC for both EBNA1 and
TRF2. RNase A treatment reduced EBNA1 recruitment of ORC at
OriP and EBNA1 association with mitotic chromosomes suggest-
ing that RNA-binding was important for viral genome replication
and episome maintenance.
While the endogenous RNAs bound by EBNA1 and TRF2 have
not been fully characterized, both EBNA1 and TRF2 bound to
telomere repeats-containing RNA (TERRA) with high afﬁnity
using in vitro binding assays including RNA pull-down assays and
EMSA (Deng et al., 2009). Endogenous TERRA bound most efﬁ-
ciently to TRF2 and TRF1 using RNA-ChIP assays. In contrast,
EBNA1 did not bind efﬁciently to endogenous TERRA, but does
interact efﬁciently with viral-encoded EBV-encoded RNA (EBER)
small non-coding RNAs expressed in close proximity to OriP
(Snudden et al., 1994; Lu et al., 2004). The role of RNA-binding
by EBNA1 and TRF2 in ORC recruitment is not completely clear.
Depletion of TERRA RNA using siRNA resulted in a change in
histone modiﬁcations within the telomere repeats and adjacent
subtelomeric regions. TRF2 andTRF1, aswell as their counterparts
in different species, have been implicated in telomere replication,
and it remains possible that RNA-binding and interactions with
ORC play a signiﬁcant role in telomere chromatin structure and
regulation.
CHROMATIN STRUCTURE OF VIRAL TERMINI
The chromatin structure of viral maintenance elements may share
common features with telomeric chromatin (Figure 2). Telomeric
chromatin is highly dynamic and can adopt multiple conforma-
tions to coordinate cell cycle regulated changes in transcription
and DNA replication (Cesare and Karlseder, 2012). Transcrip-
tion of TERRA may facilitate telomere DNA replication, as well
as promote subsequent heterochromatin formation. TRF2 and
TRF1 binding to TERRA can stabilize ORC-binding and ORC-
associated heterochromatin at telomeres (Deng et al., 2009). At
EBV OriP, EBNA1 and TRF2 may bind to viral-encoded EBER
RNA, rather than TERRA, to recruit ORC (Norseen et al., 2008).
ORC is recruited to the KSHV TR through interactions with
latency-associated nuclear antigen (LANA), but it is not known if
this interaction has an RNA-binding component (Stedman et al.,
2004). LANAbinds toKSHVTRs, and functions, like EBVEBNA1,
to tether the viral genome to metaphase chromosomes. In con-
trast to EBNA1, LANA targets metaphase chromosomes through
interactions with histone H2A/H2B (Barbera et al., 2006). LANA
also interacts with other host chromatin factors, including ORC,
BRD2/4, DEK, p53, and DNMT3a, which may affect chromatin
structure and maintenance of the TR (Ballestas and Kaye, 2011;
Verma et al., 2007). These comparative studies suggest that ORC
FIGURE 2 | Model of higher order chromatin structures at telomeres
and viral maintenance elements. RNA-dependent recruitment of ORC at
telomeres and EBV OriP is indicated. Elevated histone H3K4me3 and
CTCF-cohesin enrichment is found at all three maintenance elements.TRFs
are localized to the latent origin of both EBV and KSHV.
and heterochromatin formation play a central role in genome
maintenance function.
Recent studies have also implicated CCCTC-binding factor
(CTCF) and cohesin in the higher order chromatin struc-
ture of telomeres and viral maintenance elements (Deng et al.,
2012). CTCF and cohesin were found to bind to the majority
of human subtelomeres in close proximity to the presump-
tive start sites of TERRA transcripts. CTCF and cohesin have
been shown to bind to regions surrounding EBV OriP and
mediate long-distance enhancer–promoter regulatory interactions
and chromatin boundary functions (Tempera et al., 2010, 2011).
Nucleosome mapping studies indicate that histones are strongly
positioned at sites adjacent to theEBVandKSHVmaintenance ele-
ments (Zhou et al., 2005). The positioned histones are elevated in
H3K4me3, which is also elevated among histones neighboring the
CTCF sites in human subtelomeres. Higher order chromatin struc-
ture may also form at the EBV TRs, and mediated, in part, through
binding sites for Pax5 (Arvey et al., 2012), a cellular factors impli-
cated in chromatin condensation during immunoglobulin gene
rearrangements in B-lymphocytes (Fuxa et al., 2004). These obser-
vations suggest that viral maintenance elements and telomeres
may adopt similar higher order chromatin structures, which may
facilitate mobilization and re-localization to subcellular domains.
Viruses and telomeres can colocalize at common subnuclear
structures, including nuclear pores, nuclear periphery, and
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promyelocytic leukemia (PML) nuclear bodies (PML-NBs).
PML-NBs have been implicated in anti-viral functions, as well
as in chromatin repression, and telomere recombination (Hen-
son et al., 2002; Everett and Chelbi-Alix, 2007; Brouwer et al.,
2009; Draskovic et al., 2009; Chung et al., 2012). The primary
cellular constituents of PML-NBs, including PML, SP100, death-
domain associated protein (Daxx), and alpha thalassemia/mental
retardation syndrome X-linked (ATRX), function in chromatin
assembly and regulation. Daxx is commonly associated with his-
tone deacetylases (HDACs) andATRX is a histone H3.3 chaperone
with SNF-like ATPase remodeling activity. Recent studies have
implicated ATRX in the deposition of H3.3 at telomere repeats
and other GC-rich repetitive DNA elements (Goldberg et al., 2010;
Lewis et al., 2010). Cells lacking or depleted in ATRX have an
increase in TERRA abundance, indicating that ATRX is involved
in transcriptional repression at telomere repeat DNA (Goldberg
et al., 2010). ATRX and Daxx are known to repress viral tran-
scription and replication, but other than recruitment of HDACs,
little is known about the mechanism of viral genome repression.
Sequestration of GC-rich repetitive regions may be a common
function for PML-NBs, but it is also possible that free DNA ends
require specialized histone chaperone and assembly machinery.
Most DNA viruses encode proteins that disrupt or alter the func-
tion of PML-NBs and their various components (Tavalai and
Stamminger, 2009). Herpes simplex virus (HSV) encodes ICP0,
which functions as an E3 ubiquitin ligase that targets PML degra-
dation (Everett and Chelbi-Alix, 2007). Human cytomegalovirus
(hCMV) encodes tegument protein pp71 that degrades Daxx
(Hwang and Kalejta, 2009), and EBV encodes EBV major tegu-
ment protein (BNRF1) protein that disrupts ATRX interaction
with Daxx (Tsai et al., 2011). These viral proteins may be predicted
to affect telomere chromatin and transcription regulation, but it is
not clear if they selectively target chromatin at viral termini rather
than cellular telomeres.
TRANSCRIPTION OF VIRAL TERMINI
Transcription of viral and cellular TRs may contribute to genome
maintenance and stability. Transcription of cellular telomeres has
been detected in almost all organisms where it has been investi-
gated. TERRA is expressed from multiple different telomeres in a
largely heterogeneousmanner (Azzalin et al., 2007; Schoeftner and
Blasco, 2008). The regulation and function of telomeric RNA has
been reviewed in detail elsewhere (Arora et al., 2011; Chawla and
Azzalin, 2008; Feuerhahn et al., 2010). The TRs of several viruses
can be transcribed, potentially generating transcripts similar to
TERRA. The terminal TTAGGG repeats of HHV6 and MDV have
the potential to generate viral TERRA, but this has not yet been
experimentally identiﬁed. It is also possible that viral genomes
integrated in cellular telomeres can regulate telomere transcrip-
tion and chromatin. Reactivation of latent virus that is integrated
into viral telomeresmay correlatewith activationof viral TTAGGG
transcription.
The TRs of EBV can be transcribed, but only after genome
circularization. Genome circularization generates the template
required for the viral-encoded proteins LMP2a and LMP2b (Laux
et al., 1989). Latent membrane protein 2 (LMP2) promoter is
located in the unique right region of the viral genome, and
transcription proceeds rightward across the TR junction and con-
tinues into the fused unique left region of the viral genome. LMP2
is a highly spliced mRNA, and the TRs themselves do not con-
tribute to the open reading frame. LMP2 provides an important
B-cell survival function, as well as inhibits viral lytic cycle reactiva-
tion (Brinkmann and Schulz, 2006; Longnecker, 2000; Rechsteiner
et al., 2008). It may be possible that genome circularization and
LMP2 template formation is coordinately regulated with host-cell
growth and survival pathways.
The TR of HSV encode latency-associated transcript (LAT),
the primary transcript expressed during latent infection in neu-
ronal ganglia (Bloom, 2004). The full length LAT is generated
from a fused or circularized junction of viral TRs, similar to
the TR template for EBV-encoded LMP2. The LAT transcript is
processed into a stable 2.0 kb intron and several miRNAs (Atana-
siu and Fraser, 2007; Umbach et al., 2008). The LAT transcript
provides an anti-apoptotic activity to the latently infected neu-
ronal cells (Perng et al., 2000), and at least one miRNA that
suppresses viral lytic cycle reactivation (Umbach et al., 2008).
The LAT transcript may also interact with chromatin regulatory
factors, including members of the polycomb family, which may
regulate viral genome stability during latent infection (Kwiatkowski
et al., 2009).
DNA REPLICATION OF REPETITIVE ELEMENTS
Telomere DNA replication has been reviewed comprehensively
elsewhere (Chakhparonian and Wellinger, 2003; Gilson and Geli,
2007; Verdun and Karlseder, 2007; Cesare and Reddel, 2008;
Ye et al., 2010b; Stewart et al., 2012). We consider here only a
few aspects of telomere replication that reﬂect the relationship
between virus and host genome maintenance. As mentioned
above, both EBV and KSHV maintenance elements efﬁciently
recruit ORC. Nevertheless, replication can initiate at sites out-
side of these origins (Norio and Schildkraut, 2004; Verma et al.,
2011). ORC-binding sites have been mapped to the subtelomeric
X and Y’ elements of Saccharomyces cerevisiae, but replication ini-
tiation may not occur frequently at these potential origins. ORC
can also bind to host chromosome regions enriched in telom-
eric repeat DNA (Deng et al., 2007). However, initiation of DNA
replication occurs infrequently at telomere repeats (Sfeir et al.,
2009), and appears to initiate primarily within the large subtelom-
eric regions (Drosopoulos et al., 2012). These ﬁndings suggest
that origin function at these sites is auxillary, and that the pri-
mary function of ORC recruitment is in heterochromatin forma-
tion and DNA repeat stability (Prasanth et al., 2010; Chakraborty
et al., 2011).
Telomere repeat-binding factors may play a role in coordi-
nating replication with recombination. Myb-family proteins, like
TRF1 and TRF2, may have intrinsic capacity to modulate DNA
polymerase progression. In vitro, both TRF1 and TRF2 stall
DNA replication forks (Ohki and Ishikawa, 2004). However, in
vivo TRF1 prevents replication fork stalling and facilitates telom-
ere DNA replication (Sfeir et al., 2009); TRF2 also contributes
to efﬁcient telomere replication in vivo by regulating topologi-
cal stress (Ye et al., 2010a). Similarly, the ﬁssion yeast telomere
repeat factor Taz1 promotes DNA replication through telomere
repeats, potentially suppressing DNA secondary structures that
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block polymerase processivity (Miller et al., 2006; Dehé et al.,
2012). In contrast, some myb family members, like REB1 and
RTF1 in budding yeast, functions as a replication fork blocking
protein that regulate DNA catenation and replication termination
(Biswas and Bastia, 2008; Eydmann et al., 2008). Replication fork
regulation may play important roles in controlling recombination
and sister-chromatid cohesion, both of which are critical for viral
and cellular genome maintenance.
The viral encoded origin-binding proteins for EBV and KSHV,
EBNA1 and LANA, also cause replication fork stalling (Dheekollu
andLieberman,2011). Recent studies indicate that replication fork
stalling result in the recruitment of the replisome protection factor
Timeless (Dheekollu et al., 2011). Timeless is the human ortholog
of the Saccharomyces cerevisiae Tof1 and the Schizosaccharomyces
pombe Swi1. Its function in replication fork protection appears
to be conserved. Recently, TRF1 has been shown to interact with
Timeless at mammalian telomeres and was required for telomere
length maintenance and integrity (Leman et al., 2012). Replisome
protection may be required to prevent loss of repeat elements dur-
ing semi-conservative replication. Timeless has also been shown
to contribute to sister-chromatid cohesion in mammalian cells
(Leman et al., 2010; Dheekollu et al., 2011). Sister-chromatid cohe-
sion may be important for repeat stability, but may also contribute
to faithful chromosome segregation. Thus, viral episome main-
tenance elements may utilize telomeric mechanisms for DNA
replication and sister-chromatid cohesion.
RETROTRANSPOSITION: A VIRAL-MECHANISM OF
TELOMERE MAINTENANCE
Retrotransposons are endogenous retroviral-like DNA elements
that drive genome diversiﬁcation during evolution (Burns and
Boeke, 2012; Silva-Sousa et al., 2012). In Drosophila, telomeres
consist of retrotransposons that modulate chromosome length
by site-speciﬁc transposition at the termini (Zhang and Rong,
2012). In Bombyx mori, transposition occurs within a pentameric
telomere repeat and may compete with telomerase elongation
mechanisms (Tatsuke et al., 2009; Osanai-Futahashi and Fujiwara,
2011). Site-directed retrotransposition is thought to involve an
RNA-binding and nuclear import activity of the GAG protein
that is then directed to the site of RNA origination. Although
there is no evidence for retrotransposition as a mechanism of
mammalian telomere maintenance, it is interesting to note that
TERRA transcripts are retained at telomeres through interac-
tionswith telomere-associated proteins, includingTRF2 andTRF1
(Deng et al., 2009; Bifﬁ et al., 2012). Retention of TERRA RNA at
telomeres is likely to inﬂuence DNA replication, either through
the direct inhibition of telomerase (Schoeftner and Blasco, 2008;
Redon et al., 2010), or by controlling resection by nucleases like
ExoI (Pfeiffer and Lingner, 2012). In ALT cells, TERRA may con-
tribute to recombination-based telomere elongation, but details of
this potential mechanism have not been characterized completely.
As mentioned above, virus replication mechanisms may utilize
RNA-facilitated DNA recombination (Rennekamp and Lieber-
man, 2010, 2011). Thus, components of RNA-directed replication
that occurs in lower eukaryotic retrotransposons, may be retained
in telomere maintenance mechanisms in higher eukaryotes and
their viruses.
VIRAL MODULATION OF HOST TELOMERE
MAINTENANCE
Immortalizing viral infections rewire host control of the cell
cycle and DNA replication, including telomerase activation and
telomere elongation. Most of the known viral mechanisms
for telomerase activation involve transcriptional activation of
human telomerase reverse transcriptase (hTERT). Human papil-
lomavirus (HPV) E6 activates hTERT transcription through a
cMyc-dependent pathway (Moody and Laimins, 2010), while
KSHV LANA activates hTERT through Sp1 (Verma et al., 2004).
EBV activates hTERT in two stages, the ﬁrst following B-cell
proliferation, and the second as a bypass to crisis-associated cel-
lular senescence (Sugimoto et al., 2004; Takahashi et al., 2003).
At least one EBV encoded protein, latent membrane protein
1 (LMP1), activates hTERT through the NF-κB pathway (Ter-
rin et al., 2008). For EBV, lytic reactivation typically occurs in
response to various cellular stresses, and typically requires cell
cycle arrest. It is therefore interesting that hTERT was found
to inhibit EBV lytic replication (Terrin et al., 2007). This sug-
gests that telomerase activation status may modulate viral infec-
tion and replication, just as viral infection affects telomerase
activation.
Non-immortalizing viruses may also affect telomerase activity
of the infected cell. hCMV has been reported to induce telom-
erase through induction of hTERT transcription during primary
infection of human diploid ﬁbroblasts (Straat et al., 2009). This
has been proposed as a potential mechanism of hCMV car-
cinogenesis. Chromosome instability and telomere shortening
have been reported in cells chronically infected with hepatitis B
virus (HBV) and in HBV-associated hepatocellular carcinoma
(HCC; Lee et al., 2009). This correlated with an upregulation
in shelterin proteins TRF1 and TRF2 in HCC foci (Oh et al.,
2005). The chronic infection associated with HCV, an RNA
virus, has also been reported to affect telomerase. The HCV core
particle can increase telomerase nuclear localization and activ-
ity when co-expressed in hepatocellular carcinoma cell lines (Zhu
et al., 2010).
Viruses can also cause telomere dysfunction independently
of telomerase activation. EBV infected cells have been shown
to have dysfunctional telomeres (Kamranvar and Masucci, 2011;
Kamranvar et al., 2007; Lacoste et al., 2009; Figure 3). EBNA1
has been implicated in the induction of telomere dysfunction
through generation of reactive oxygen species (ROS) by tran-
scription control of NOX2 (Gruhne et al., 2009; Kamranvar and
Masucci, 2011). EBV-associated tumors, including EBV positive
Reed-Sternberg cells in Hodgkin’s lymphoma may have altered
telomere morphology and organization (Knecht et al., 2010a,b).
Telomere clustering has been observed in several cancer cells, and
virus induced proliferation may contribute to changes in telomere
organization.
Viruses may also cause telomere dysfunction by integration
into host telomeric DNA. HHV6 or MDV efﬁciently integrate into
the host telomeric DNA through homologous recombination with
the telomeric repeats at the viral termini. Viral TRs and telomere
integration have a profound effect on MDV tumorigenesis and
T-cell lymphomas. Although the potential direct effect on telom-
ere dysfunction to MDV carcinogenesis is not known, telomere
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FIGURE 3 | EBV primary infection induces telomere dysfunction
in peripheral blood mononuclear cells (PBMCs). (A) Freshly isolated
PBMCs (#187 and #225) were infected with viruses isolated from
Mutu I cells, and assayed by telomere DNA ﬂuorescence in situ hybridi-
zation (FISH) on metaphase spreads at day 50 post-infection using
telomeric PNA probe (green). Metaphase chromosomes were stained by
Dapi, and shown in blue. (B) Common telomere aberrations in infected
cells were shown as enlarged images. Arrows indicate telomere doublets
(i–ii), telomere end fusions (iii–iv), and telomeric signal free ends
(v–vi).
integration was shown to be important for efﬁcient genome main-
tenance in infected cells (Kaufer et al., 2011b). Integration of
HHV6 has no known pathology, but may correlate with cognitive
and other neurological disorders. Whether this is due to telomere
integration and telomere dysfunction is not yet known (Montoya
et al., 2012).
Viral proteins can also bind telomeric factors and alter their
ability to maintain telomere structure. HPV E6 has been shown
to interact directly with the telomerase complex at telomeric
DNA and this contributes to keratinocyte transformation by
HPV (Liu et al., 2009). KSHV LANA has been shown to inter-
act with both TRF1 and TRF2, and cause telomere shortening
(Shamay et al., 2012). Consistent with LANA binding to TRF2
is the observation that TRF2 can also localize to the LANA-
binding sites at the KSHV origin of replication (Hu et al.,
2009). EBV EBNA1 was found to bind directly to Tankyrase,
the TRF1-associated poly-ADP ribosylating enzyme (Deng et al.,
2005). Tankyrase can modify EBNA1 and down-regulate its
binding and function at OriP. Whether EBNA1 alters Tankyrase
function at telomeres during EBV latent infection has not
been determined. In summary, numerous interactions between
viral proteins and host telomere regulatory factors have been
reported. These reports underscore the signiﬁcance of targeting
telomeres and telomere maintenance mechanisms during viral
infection.
CONCLUSIONS
Viruses, like their hosts, actively and competitively maintain
their genomes. In the process, virus infections may destabiliz-
ing host genomes with the consequence of cytopathic effects that
can include carcinogenic insult. Many viruses, especially persis-
tent DNA viruses, have specialized genome maintenance elements
similar to host chromosomes. In this review, we have high-
lighted the numerous and diverse molecular mechanisms that
contribute to TR stability, especially those that are shared by
viruses and their host cells. Remarkably, these maintenance ele-
ments are themselves inherently unstable. Their repetitive nature
makes them vulnerable to recombination and rearrangements.
Theirmechanismsof self-replication andpost-replicationprocess-
ing are also threats to genetic stability. Understanding how these
highly dynamic genetic elements balance genome stability with
genome diversiﬁcation is crucial to our understanding the forces
that drive viral infection and cancer cell evolution. The knowledge
gained from studying viral mechanisms of genome mainte-
nance may provide insights into new anti-viral and anti-cancer
therapies.
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